Systemic and metabolic effects of PDE5-inhibitor drugs

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

661

HTML

6281

Figures (1-1)

712

Tables (1-3)

801

Sum=8455

Mar 15, 2010 (publication date) through Jan 30, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Mar 15, 2010; 1(1): 3-7
Published online Mar 15, 2010. doi: 10.4239/wjd.v1.i1.3

Table 3 Causes and main interventions in endothelial dysfunction

Factors associated with endothelial dysfunction	Interventions to correct endothelial dysfunction
Aging	L-arginine
Male sex	Estrogens
Cigarette smoking	Smoking cessation
History of CHD	Antioxidants
Low HDL- and high LDL-COL	Statins
Hypertension	ACE-i
Hyperomocysteinemia	Homocysteine lowering (folates)
Diabetes/obesity	Exercise
Erectile dysfunction	PDE5-i

Citation: Aversa A. Systemic and metabolic effects of PDE5-inhibitor drugs. World J Diabetes 2010; 1(1): 3-7
URL: https://www.wjgnet.com/1948-9358/full/v1/i1/3.htm
DOI: https://dx.doi.org/10.4239/wjd.v1.i1.3